(Q41126585)

27 September 2017

1 reference

title

Dose-intensified treatment of breast cancer: current results (English)

1 reference

27 September 2017

C von Schilling

1

1 reference

27 September 2017

F Herrmann

series ordinal

2

1 reference

27 September 2017

publication date

1 December 1995

1 reference

Journal of Molecular Medicine

27 September 2017

published in

1 reference

27 September 2017

volume

73

1 reference

27 September 2017

issue

12

1 reference

27 September 2017

page(s)

611-627

1 reference

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

27 September 2017

cites work

1 reference

12 December 2020

High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age

1 reference

12 December 2020

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

1 reference

12 December 2020

Age as prognostic factor in premenopausal breast carcinoma

1 reference

12 December 2020

The Relationship Between Micrometastases in the Bone Marrow, Histopathologic Features of the Primary Tumor in Breast Cancer and Prognosis

1 reference

12 December 2020

Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results

1 reference

12 December 2020

Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide

1 reference

12 December 2020

Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes

1 reference

12 December 2020

Diverse prognosis in metastatic breast cancer: who should be offered alternative initial therapies?

1 reference

12 December 2020

The Norton-Simon hypothesis revisited

1 reference

12 December 2020

Use of Very-High-Dose Chemotherapy With Autologous Bone Marrow Transplantation in Treatment of Breast Cancer

1 reference

12 December 2020

1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings

1 reference

12 December 2020

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up

1 reference

12 December 2020

White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support

1 reference

12 December 2020

Late intensification with high-dose melphalan and autologous bone marrow support in breast cancer patients responding to conventional chemotherapy

1 reference

12 December 2020

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer

1 reference

12 December 2020

Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors

1 reference

12 December 2020

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team

1 reference

12 December 2020

High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

1 reference

12 December 2020

Treatment of metastatic breast cancer with a split-course high-dose chemotherapy regimen and autologous bone marrow transplantation

1 reference

12 December 2020

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

12 December 2020

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

12 December 2020

High–dose melphalan with autologous bone marrow transplant treatment of poor prognosis tumors

1 reference

12 December 2020

High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer

1 reference

12 December 2020

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors

1 reference

12 December 2020

Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases

1 reference

12 December 2020

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

1 reference

12 December 2020

Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients

1 reference

12 December 2020

Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy

1 reference

12 December 2020

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy

1 reference

12 December 2020

Evolving concepts in the systemic adjuvant treatment of breast cancer.

1 reference

12 December 2020

Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma

1 reference

12 December 2020

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer

1 reference

12 December 2020

Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment

1 reference

12 December 2020

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma

1 reference

12 December 2020

Prognostic factors in inflammatory breast cancer and therapeutic implications

1 reference

12 December 2020

A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group

1 reference

12 December 2020

Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities

1 reference

12 December 2020

Bone marrow autotransplantation for solid tumors--prospects

1 reference

12 December 2020

Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques

1 reference

12 December 2020

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

12 December 2020

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

12 December 2020

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

1 reference

12 December 2020

Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support

1 reference

12 December 2020

High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer

1 reference

12 December 2020

Alkylating agent resistance: in vitro studies with human cell lines

1 reference

12 December 2020

Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood

1 reference

12 December 2020

Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer

1 reference

12 December 2020

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

1 reference

12 December 2020

Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer

1 reference

12 December 2020

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer

1 reference

12 December 2020

Combination of N,N',N"-triethylenethiophosphoramide and cyclophosphamide in vitro and in vivo

1 reference

12 December 2020

Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy

1 reference

12 December 2020

Pathological assessment of response to induction chemotherapy in breast cancer

1 reference

12 December 2020

Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study

1 reference

12 December 2020

Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis

1 reference

12 December 2020

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

1 reference

12 December 2020

High-dose therapy: here to stay or just visiting?

1 reference

12 December 2020

Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast

1 reference

12 December 2020

Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug Therapy

1 reference

12 December 2020

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

12 December 2020

Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support

1 reference

12 December 2020

Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Adjuvant systemic therapy and survival after breast cancer

1 reference

12 December 2020

High-dose combination alkylating agent therapy with autologous bone marrow rescue for refractory solid tumors

1 reference

12 December 2020

Inflammatory breast cancer: a review

1 reference

12 December 2020

High-dose chemotherapy supported by autologous bone marrow transplantation in solid tumors

1 reference

12 December 2020

Treatment of disseminated cancer by intravenous hydroxyurea and autogenous bone-marrow transplants: Experience with 35 patients

1 reference

12 December 2020

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial

1 reference

12 December 2020

Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte‐colony stimulating factor accelerate both neutrophil and platelet recovery after high‐dose VP16, ifosfamide and cisplatin

1 reference

12 December 2020

High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00196355

1 reference

27 September 2017

1 reference